The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.

FDA Commissioner Marty Makary defends agency leadership in NPR interview; New long COVID-19 research links disease to chronic ...

Moderna (MRNA.O), opens new tab did not immediately respond to a Reuters request for comment but has previously said that ...

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

FDA Commissioner Dr. Marty Makary says the agency has no plans to put a black box warning on Covid-19 vaccines. He says a ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

FDA decides against black box warning for Covid vaccines despite ongoing safety reviews, focusing on myocarditis concerns.

FDA Commissioner Dr. Marty Makary says the agency has no plans to put a black box warning on Covid-19 vaccines. He says a ...

Canadian researchers who examined the medical records of nearly 20,000 women who developed COVID-19 while pregnant, found ...

California Gov. Gavin Newsom announced the hiring of two former top officials with the U.S. Centers for Disease Control and ...